Differential diagnosis of mesothelial and ovarian cancer cells in ascites by immunocytochemistry using Ber-EP4 and calretinin.
Sato
S
S
Okamoto
S
S
Ito
K
K
Konno
R
R
Yajima
A
A
D018262:Adenocarcinoma, Clear Cell / Q000737:chemistry* / Q000473:pathology; D000954:Antigens, Surface / Q000032:analysis*; D014408:Biomarkers, Tumor / Q000032:analysis*; D064032:Calbindin 2; D018269:Carcinoma, Endometrioid / Q000737:chemistry* / Q000473:pathology; D018284:Cystadenocarcinoma, Serous / Q000737:chemistry* / Q000473:pathology; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D008654:Mesothelioma / Q000737:chemistry* / Q000473:pathology; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000737:chemistry* / Q000473:pathology; D064030:S100 Calcium Binding Protein G / Q000032:analysis*; D000951:Antigens, Neoplasm
D000954:Antigens, Surface; D014408:Biomarkers, Tumor; D064032:Calbindin 2; D064030:S100 Calcium Binding Protein G; C576764:CALB2 protein, human; C115012:human epithelial antigen-125; D000951:Antigens, Neoplasm